Selectivity of eligibility criteria
Criterion | Participants with current asthma excluded (%) |
---|---|
Bronchodilator reversibility ⩾15% | 76 |
Bronchodilator reversibility ⩾12% | 71 |
Peak flow variability ⩾20% | 66 |
FEV1 ⩾50% and <80% of predicted | 61 |
Inhaled corticosteroid use | 48 |
<10 pack-years of exposure to cigarette | 31 |
Active symptoms or use of rescue drugs | 20 |
FEV1 ⩾50% of predicted | 12 |